Literature DB >> 14577499

Primary embryonal rhabdomyosarcoma of prostate in adults: diagnosis and management.

G Nabi1, A K Dinda, P N Dogra.   

Abstract

Embryonal rhabdomyosarcoma of the prostate is a common tumour in infants and children. It is rarely seen in adults. The combined modality has improved outcome in children, where as in adults prognosis is poor. The lack of awareness of this entity in adults, delay in diagnosis and a more aggressive behavior of this malignancy are some of the reasons. We report two cases of embroyonal rhabdomyosarcoma of prostate in adults along with review of literature with an aim to define natural history and formulate treatment policy.

Entities:  

Mesh:

Year:  2002        PMID: 14577499     DOI: 10.1023/a:1025638711476

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  UROGENITAL RHABDOMYOSARCOMA: HISTOGENESIS AND CLASSIFICATION.

Authors:  J G BATSAKIS
Journal:  J Urol       Date:  1963-08       Impact factor: 7.450

2.  Sarcoma of the prostate: a report of four cases and a review of current therapy.

Authors:  J SIEGEL
Journal:  J Urol       Date:  1963-01       Impact factor: 7.450

3.  Sarcoma of the prostate gland.

Authors:  B H Smith; L P Dehner
Journal:  Am J Clin Pathol       Date:  1972-07       Impact factor: 2.493

4.  Embryonal rhabdomyosarcoma of the prostatic-urethral region in an adult.

Authors:  D J Keenan; W H Graham
Journal:  Br J Urol       Date:  1985-04

5.  Rhabdomyosarcoma of the prostate.

Authors:  W T Lemmon; J M Holland; A S Ketcham
Journal:  Surgery       Date:  1966-05       Impact factor: 3.982

6.  Pleomorphic rhabdomyosarcoma in adults: immunohistochemistry as a tool for its diagnosis.

Authors:  A S de Jong; M van Kessel-van Vark; C E Albus-Lutter
Journal:  Hum Pathol       Date:  1987-03       Impact factor: 3.466

7.  Embryonal rhabdomyosarcoma of the prostate.

Authors:  D G King; R P Finney
Journal:  J Urol       Date:  1977-01       Impact factor: 7.450

8.  Rhabdomyosarcoma of prostate in adult. Long-term survival and problem of histologic diagnosis.

Authors:  W B Dupree; C Fisher
Journal:  Urology       Date:  1982-01       Impact factor: 2.649

Review 9.  Prostatic embryonal rhabdomyosarcoma in adults. A clinicopathologic review.

Authors:  P M Waring; R C Newland
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

10.  Transrectal ultrasound in the evaluation of rhabdomyosarcoma involving the prostate.

Authors:  M K Terris; E B Eigner; E M Briggs; J H Reese; F M Torti; F S Freiha
Journal:  Br J Urol       Date:  1994-09
View more
  5 in total

1.  Prostate embryonal rhabdomyosarcoma in adults: Case report and review of literature.

Authors:  Patrizia Ciammella; Maria Galeandro; Nunziata D'Abbiero; Tamara Palmieri; Elisa Donini; Cinzia Iotti
Journal:  Rep Pract Oncol Radiother       Date:  2013-06-21

Review 2.  Spindle cell embryonal rhabdomyosarcoma of the prostate in an adult patient - case report and review of clinicopathological features.

Authors:  Hans-Ulrich Schildhaus; Suvi Lokka; Werner Fenner; Jens Küster; Ingrid Kühnle; Ernst Heinmöller
Journal:  Diagn Pathol       Date:  2016-06-29       Impact factor: 2.644

3.  Cytoreductive robot-assisted prostatectomy for systemic prostate rhabdomyosarcoma presenting as urinary retention.

Authors:  Takahiro Kirisawa; Arinobu Fukunaga; Hajime Takamori; Aiko Maejima; Yasuo Shinoda; Motokiyo Komiyama; Hiroyuki Fujimoto; Kan Yonemori; Akihiko Yoshida; Yoshiyuki Matsui
Journal:  IJU Case Rep       Date:  2021-12-29

4.  Embryonal prostatic rhabdomyosarcomas disguised presentation in an adolescent male: a case report.

Authors:  Nishith K Singh; Malatesha Gangappa; Vineet Gupta; Anant Mohan
Journal:  Cases J       Date:  2009-08-26

5.  Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas.

Authors:  Jonathan D Tward; Matthew M Poppe; Ying J Hitchcock; Brock O'Neil; Daniel J Albertson; Dennis C Shrieve
Journal:  Cancer Med       Date:  2018-11-19       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.